A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
11/1998
11/10/1998	US5833964 No noticable white residue; active ingredient, gelling agent, emollient with refractive index of at least 1.4460
11/10/1998	US5833958 Dentifrice compositions
11/05/1998	WO1998049166A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
11/05/1998	WO1998049138A2 Vitamin d3 analogs with bis c-20 side chains
11/04/1998	EP0875515A2 "Sulfatation of estrogen mixtures"
11/04/1998	EP0874631A1 Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application
11/04/1998	EP0552227B2 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation
11/03/1998	US5830882 Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
10/1998
10/29/1998	WO1998047533A1 Ultrasound imaging of tissue perfusion by pulse energy disruption of contrast agent
10/29/1998	WO1998047473A1 Use of unsaturated aldehydes in dying fibers containing keratin
10/29/1998	DE19717224A1 Verwendung von ungesättigten Aldehyden zum Färben von keratinhaltigen Fasern The use of unsaturated aldehydes for dyeing keratin fibers
10/29/1998	CA2288055A1 Use of unsaturated aldehydes in dying fibers containing keratin
10/28/1998	EP0674651B1 Substituted 6-azaandrostenones
10/27/1998	US5827834 Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease
10/27/1998	US5827832 Method of protecting brain tissue from cerebral infarction subsequent to ischemia
10/27/1998	CA2159013C Non-aerosol shaving gel
10/27/1998	CA2102179C Quinuclidine derivatives
10/22/1998	WO1998046644A1 Novel protein and process for producing the same
10/22/1998	WO1998046642A1 MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA
10/22/1998	WO1998046562A1 A process for the preparation of 4-bromomethyl diphenyl compounds
10/22/1998	WO1998046244A1 Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine
10/22/1998	WO1998046243A2 Pharmaceutical compositions having appetite suppressant activity
10/22/1998	WO1998046207A1 Compositions containing an antifungal and a cationic agent
10/22/1998	CA2781623A1 Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same
10/22/1998	CA2584411A1 Pharmaceutical compositions having appetite suppressant activity
10/22/1998	CA2289476A1 Modified tnf.alpha. molecules, dna encoding such modified tnf.alpha. molecules and vaccines comprising such modified tnf.alpha. molecules and dna
10/21/1998	EP0872244A1 Cosmetic or pharmaceutical composition containing an Andiroba extract
10/21/1998	EP0872237A1 Method and compositions for the synthesis of BCH-189 and related compounds
10/21/1998	EP0872230A1 Compositions containing an antifungal and a cationic agent
10/21/1998	EP0871479A2 Oral administration of pneumococcal antigens
10/21/1998	EP0871429A1 Clear cosmetic stick composition
10/21/1998	CN1040321C Pyran-2-ones and 5,6-dihydropyran-2-ones, medicine composition containing them and pharmacy use thereof
10/20/1998	US5824653 Anthelmintic compositions for equidae
10/15/1998	WO1998045328A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/15/1998	WO1998044936A2 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations
10/15/1998	WO1998044898A1 Depilatory compositions, their preparation and use
10/15/1998	DE19714450A1 Stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und pharmazeutische Zubereitung Stable extract of Hypericum perforatum L., process for its preparation and pharmaceutical preparation
10/15/1998	CA2286348A1 Compositions and methods for the treatment and diagnosis of breast cancer
10/15/1998	CA2286064A1 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations
10/15/1998	CA2286035A1 Depilatory compositions, their preparation and use
10/14/1998	EP0869966A1 Prodrugs of thrombin inhibitors
10/14/1998	EP0869958A1 Novel indole-2,3-dione-3-oxime derivatives
10/14/1998	EP0869810A1 Cyclosporin-containing soft capsule preparations
10/14/1998	EP0869798A1 Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)
10/14/1998	EP0869771A1 A cosmetic composition and a method for reducing the ageing processes of skin
10/14/1998	EP0869770A1 Underarm compositions
10/14/1998	CN1195666A Intermediates of steroids, their preparation and uses
10/14/1998	CA2235057A1 A cosmetic and pharmaceutical formulation containing an andiroba extract
10/13/1998	US5821206 Composition
10/13/1998	US5820849 Cascade polymer complexes, process for their production and pharamceutical agents containing said complexes
10/08/1998	WO1998043945A1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
10/08/1998	WO1998043650A1 A method and a tobramycin aerosol formulation for treatment, prevention and containment of tuberculosis
10/08/1998	WO1998043605A1 Antiperspirant stick with improved characteristics
10/08/1998	WO1998016646A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/07/1998	EP0868918A2 Vaccines
10/07/1998	EP0868907A2 Constitutive part of a skin-care product
10/07/1998	EP0868197A1 Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage
10/07/1998	EP0868185A1 Method for treating depression
10/07/1998	CN1195353A New inhibitors of platelet aggregation
10/06/1998	US5817664 Uracil reductase inactivators
10/06/1998	US5817640 Acadesine
10/06/1998	US5817609 Bar composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers
10/01/1998	WO1998042820A1 Use of the antibacterial active substance triclocarbane in liquid soaps
10/01/1998	WO1998042705A1 Salt of naphthyridine carboxylic acid derivative
10/01/1998	WO1998042675A1 Substituted isoquinolines as ultra short acting neuromuscular blockers
10/01/1998	WO1998042674A1 Substituted isoquinolines as ultra short acting neuromuscular blockers
10/01/1998	WO1998042379A2 Chemically and thermally stable norastemizole formulations
10/01/1998	WO1998042340A1 Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus
10/01/1998	WO1998042321A2 Liquid compositions comprising lamivudine
10/01/1998	DE19712410A1 Verwendbarkeit des antibakteriellen Wirkstoffes Triclocarban in Flüssigseifen Usability of the antibacterial agent triclocarban in liquid soaps
10/01/1998	CA2284776A1 Use of the antibacterial active substance triclocarbane in liquid soaps
10/01/1998	CA2284705A1 Chemically and thermally stable norastemizole formulations
10/01/1998	CA2284192A1 Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus
09/1998
09/30/1998	EP0866720A1 Methods of increasing lean tissue mass using ob protein compositions
09/30/1998	EP0708632B1 High lathering anti-dandruff shampoos
09/30/1998	EP0616494B1 1- n-(halo-3-pyridylmethyl)]-n-methylamino-1-alkylamino-2-nitroethylene derivatives for use against fleas on pets
09/30/1998	CN1039996C N-substituted azabicycloheptane devivatives and its use
09/29/1998	US5814639 Treating aids
09/29/1998	US5814340 Controlled release systems and low dose androgens
09/24/1998	WO1998041226A1 Pharmaceutical combined preparations containing erythropoietin and iron preparations
09/24/1998	WO1998041186A1 Hair dye compositions and process
09/24/1998	CA2255715A1 Hair dye compositions and process
09/23/1998	EP0865431A2 Compounds
09/23/1998	CN1193961A Substituted benzylaminopiperidine compounds
09/23/1998	CN1193907A Preparation and methods for the treatment of T cell mediated diseases
09/22/1998	US5811441 Inhibition of platelet aggregation; treatment of autoimmune diseases
09/22/1998	US5811410 Nonsteroidal antiinflammatory drugs
09/22/1998	US5811102 Modified meningococcal polysaccharide conjugate vaccines
09/22/1998	US5811096 Comprises urate oxidase and poloxamer in buffered aqueous medium
09/22/1998	US5811082 Wax particles containing dispersed metal oxide particles
09/17/1998	WO1998040331A1 Preparation of preparing substituted indanones
09/17/1998	WO1998040053A1 Dosage forms comprising separate portions of r- and s-enantiomers
09/17/1998	WO1998024404A3 Antiperspirant composition in stick form
09/16/1998	EP0712309B1 Hair styling compositions containing a silicone grafted polymer and low level of a volatile hydrocarbon solvent
09/16/1998	EP0650496B1 Anti-inflammatory compounds for ophthalmic use
09/16/1998	CN1193273A Cosmetic composition including acrylic anionic polymer and oxyalkylene silicone
09/15/1998	US5807867 Quinuclidine derivatives
09/15/1998	CA2025668C Use of omeprazole as an antimicrobial agent
09/11/1998	WO1998039012A1 USE OF A 7α-METHYL-17α-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS
09/11/1998	WO1998030193A3 Bar composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers

1 ... 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 ... 295